ALFA FinderNSE filing, NSE: PNGSREVA. Summary written from the filing by ALFA Finder's alert engine.
PNGS Reva Diamond Jewellery Ltd: key numbers
- Share price
- ₹618.80
- Market cap
- ₹1,962 Cr
- Revenue (annual)
- ₹439.0 Cr
- Net profit (annual)
- ₹64.66 Cr
- P/E (TTM)
- 20.6×Sector 48.4×
- Promoter holding
- 64.77%+0.00% QoQ
- FII holding
- 3.42%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PNGS Reva Diamond Jewellery Ltd
All →PNGS Reva Diamond Jewellery Other Announcement
PNGS Reva Diamond Jewellery filed its quarterly shareholding pattern for the period ended 30 September 2026. This is a routine Reg 31 disclosure with no transaction or business event.
PNGS Reva Diamond Jewellery Capacity Expansion
PNGS Reva Jewellery opened its 6th exclusive brand store at Bavdhan, Pune. Total stores now stand at 34 SIS and 6 EBOs.
- Exclusive Brand Stores (EBO) opened
- 1 stores
PNGS Reva Diamond Jewellery Other Announcement
PNGS Reva filed CARE Ratings' monitoring report on IPO fund use for the quarter ended September 2026. It flags a delay in utilising proceeds.
PNGS Reva Diamond Jewellery Investor Presentation: Key Takeaways
Q2FY27 ex-gold revenue Rs1,205Mn (+46%), PAT Rs233Mn (+84%). H1FY27 revenue Rs2,385Mn, PAT Rs505Mn (+151%). Store expansion and e-commerce launch.
PNGS Reva Diamond Jewellery Q2 FY27 Results: Net Profit ₹23.3 Cr, Up 83.5% YoY
PNGS Reva Diamond Jewellery Ltd reported revenue from operations of ₹120.5 Cr (+17.0% YoY) and net profit of ₹23.3 Cr (+83.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹23.3 Cr · +83.5% YoY
PNGS Reva Diamond Jewellery Board Meeting Date
PNGS Reva Diamond Jewellery scheduled its Board Meeting for October 26, 2026. The agenda includes approval of Q2 and H2 FY27 unaudited financial results.
Other product launch announcements
All →HCL Technologies Product Launch
HCLTech launched a pre-configured semiconductor PLM solution built on PTC Windchill, developed in collaboration with PTC. The release states no contract value or deal size, and the launch is a new product offering.
Morepen Laboratories Product Launch
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.
AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.
JBM Auto Product Launch
JBM Electric Vehicles launched the all-electric ECOLIFE e12 city bus at Singapore Urban Mobility Week 2026. It cites 20,000-bus annual capacity and a new Singapore APAC hub.
- electric bus manufacturing capacity
- 20000.0 buses per annum